Gene: OXCT2
Official Full Name: 3-oxoacid CoA-transferase 2provided by HGNC
Gene Summary: The protein encoded by this gene catalyzes the transfer of a CoA group from succinate to acetoacetate and is an important enzyme in ketone body catabolism. The encoded protein localizes to the mitochondrion. This gene is intronless, and a pseudogene of this gene is located elsewhere on chromosome 1. [provided by RefSeq, Aug 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15416 | OXCT2 Knockout cell line (HeLa) | Human | OXCT2 | 1:3~1:6 | Negative | Online Inquiry |
KO15417 | OXCT2 Knockout cell line (HCT 116) | Human | OXCT2 | 1:2~1:4 | Negative | Online Inquiry |
KO15418 | OXCT2 Knockout cell line (HEK293) | Human | OXCT2 | 1:3~1:6 | Negative | Online Inquiry |
OXCT2 Gene Knockout Cell Lines are genetically engineered cellular models that enable the functional analysis of the OXCT2 gene, which encodes for the 2-oxoglutarate transporter involved in metabolic processes. These knockout cell lines are developed using CRISPR/Cas9 technology to precisely delete the OXCT2 gene, allowing researchers to study its role in a variety of metabolic pathways, particularly in the context of cancer metabolism and neurodegenerative disorders.
The primary function of OXCT2 involves the transport of 2-oxoglutarate, a key intermediate in the tricarboxylic acid (TCA) cycle, which is crucial for cellular energy production and biosynthesis. By observing the physiological changes in OXCT2 knockout cell lines, researchers can elucidate the gene's contribution to metabolic dysregulation and its implications in disease progression, thus providing insights into potential therapeutic targets.
The scientific importance of OXCT2 gene knockout cell lines extends across various fields of research, including cancer biology, metabolic disorders, and neurobiology. These models serve as valuable tools for drug discovery and development, allowing for the evaluation of therapeutic strategies aimed at modulating metabolic pathways impaired in diseases.
One of the key advantages of our OXCT2 gene knockout cell lines is their precise genetic modification, which ensures that the resulting phenotype is attributable solely to the absence of the OXCT2 gene. This specificity enhances the reliability of experimental outcomes compared to alternative models that may have confounding variables. Furthermore, our commitment to rigorous quality control means that researchers can expect consistent performance and reproducibility across experiments.
For researchers and clinicians, the value of using OXCT2 knockout cell lines lies in their potential to accelerate understanding of metabolic functions and disease mechanisms, ultimately leading to improved therapeutic approaches and patient outcomes. As experts in the field of genetic engineering and cell line development, our company is dedicated to providing high-quality biological products that meet the rigorous demands of modern scientific research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.